StockMacro
Company, fund or insider

Help

Menu

OraSure Technologies

$3.46 -12% in 6 monthsMarket cap $238.9M

OSUR on XNAS, Health Care, OraSure Technologies Inc, job postings

Measures activity, not value. Not investment advice.

Quarterly revenue rose 14% and shares are up 64% in a year, but twelve-month revenue fell 7.5%.

  • BadFree cash flow was negative $49.6M over 12 months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
500
Website
orasure.com
Listed
Nasdaq, US
Last results
9 Nov 2026
Next results
expected around 24 Feb 2027 (an estimate: a year ago it reported on 25 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $30.9M, net loss $13.1M.
Quarter to 31 Dec 2021: revenue $63.6M, net income -$10.4MQuarter to 31 Dec 2021: revenue $63.6M, net income -$10.4MQuarter to 31 Mar 2022: revenue $67.7M, net income -$20.0MQuarter to 31 Mar 2022: revenue $67.7M, net income -$20.0MQuarter to 30 Jun 2022: revenue $80.2M, net income -$18.8MQuarter to 30 Jun 2022: revenue $80.2M, net income -$18.8MQuarter to 30 Sep 2022: revenue $116.5M, net income $5.3MQuarter to 30 Sep 2022: revenue $116.5M, net income $5.3MQuarter to 31 Dec 2022: revenue $123.1M, net income $15.6MQuarter to 31 Dec 2022: revenue $123.1M, net income $15.6MQuarter to 31 Mar 2023: revenue $155.0M, net income $27.2MQuarter to 31 Mar 2023: revenue $155.0M, net income $27.2MQuarter to 30 Jun 2023: revenue $85.4M, net income -$4.8MQuarter to 30 Jun 2023: revenue $85.4M, net income -$4.8MQuarter to 30 Sep 2023: revenue $89.2M, net income $11.2MQuarter to 30 Sep 2023: revenue $89.2M, net income $11.2MQuarter to 31 Dec 2023: revenue $75.9M, net income –Quarter to 31 Mar 2024: revenue $54.1M, net income -$3.6MQuarter to 31 Mar 2024: revenue $54.1M, net income -$3.6MQuarter to 30 Jun 2024: revenue $54.3M, net income -$615KQuarter to 30 Jun 2024: revenue $54.3M, net income -$615KQuarter to 30 Sep 2024: revenue $39.9M, net income -$4.5MQuarter to 30 Sep 2024: revenue $39.9M, net income -$4.5MQuarter to 31 Dec 2024: revenue $37.4M, net income –Quarter to 31 Mar 2025: revenue $29.9M, net income -$16.0MQuarter to 31 Mar 2025: revenue $29.9M, net income -$16.0MQuarter to 30 Jun 2025: revenue $31.2M, net income -$19.7MQuarter to 30 Jun 2025: revenue $31.2M, net income -$19.7MQuarter to 30 Sep 2025: revenue $27.1M, net income -$13.7MQuarter to 30 Sep 2025: revenue $27.1M, net income -$13.7MQuarter to 31 Dec 2025: revenue $26.8M, net income -$19.3MQuarter to 31 Dec 2025: revenue $26.8M, net income -$19.3MQuarter to 31 Mar 2026: revenue $27.9M, net income -$22.4MQuarter to 31 Mar 2026: revenue $27.9M, net income -$22.4MQuarter to 30 Jun 2026: revenue $30.6M, net income $6.2MQuarter to 30 Jun 2026: revenue $30.6M, net income $6.2MQuarter to 30 Sep 2026: revenue $30.9M, net income -$13.1MQuarter to 30 Sep 2026: revenue $30.9M, net income -$13.1M
31 Dec 2021RevenueNet incomeNet losstallest bar $155.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$30.9M-$13.1M
30 Jun 2026$30.6M$6.2M
31 Mar 2026$27.9M-$22.4M
31 Dec 2025$26.8M-$19.3M
30 Sep 2025$27.1M-$13.7M
30 Jun 2025$31.2M-$19.7M
31 Mar 2025$29.9M-$16.0M
31 Dec 2024$37.4M–
30 Sep 2024$39.9M-$4.5M
30 Jun 2024$54.3M-$615K
31 Mar 2024$54.1M-$3.6M
31 Dec 2023$75.9M–
30 Sep 2023$89.2M$11.2M
30 Jun 2023$85.4M-$4.8M
31 Mar 2023$155.0M$27.2M
31 Dec 2022$123.1M$15.6M
30 Sep 2022$116.5M$5.3M
30 Jun 2022$80.2M-$18.8M
31 Mar 2022$67.7M-$20.0M
31 Dec 2021$63.6M-$10.4M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $116.2M $125.7M
Revenue growthRevenue of the last 12 months compared with the 12 months before. -7.5% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$48.5M -$60.2M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.69 -$0.80
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 43.1% 40.4% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -43.8% -51.1% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -41.7% -47.9% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -14.5% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$49.6M -$43.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $148.2M $216.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$148.2M (net cash) -$216.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $4.45
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.1 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.78 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.78 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
OraSure TechnologiesOSUR (this company) $238.9Mloss2.1-7.5%-41.7%
Profound MedicalPROF $233.7Mloss9.9+65%-138%
Orthofix MedicalOFIX $247.4Mloss0.30+2.1%-5.4%
SS Innovations InternationalSSII $254.9Mloss5.5+27%-31.5%
ClearPoint NeuroCLPT $221.5Mloss4.9+33%-79.4%
NeuropaceNPCE $273.9Mloss2.9+8.9%-20.0%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+14%

$30.9M vs $27.1M (quarter ended 30 Sep 2026)

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-2.0%

146 13F filers vs 149

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

82%

56.9M shares held by 13F filers (30 Sep 2026) of 69.0M outstanding (2 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.8%

2.6M shares sold short (30 Oct 2026) of 69.0M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.6

2.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-4.3%

2.7M shares sold short in the report before, 2.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

65%

65% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 45%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

3

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$388K

the 12 months before: $174K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$10K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

5

5 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.0×

5 articles in the last 7 days; its usual week has 1.

Price $3.46 on 20 Nov 2026, +64% over 12 months (12-month range $2.11 to $4.50)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $551K in the last 12 months (the 12 months before: $761K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $30.9M in the latest quarter, +14% on a year earlier.
Capital spending per quarter. Capital spending $1.7M in the latest quarter, +82% on a year earlier.
Institutional holders (13F filers). 146 13F filers reported holding it in the latest 13F quarter, +5.0% on a year earlier.
Federal obligations. Federal obligations: $293K published in the last 12 months, +23% on the 12 months before.
Lobbying spend. Lobbying spend: $10K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
3 Jun 20268-K and other filingsDirector or officer change
17 Apr 20268-K and other filingsDirector or officer change
5 Mar 20268-K and other filingsDirector or officer change
5 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Oct 20258-K and other filingsDirector or officer change
28 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 May 20258-K and other filingsDirector or officer change
9 May 20258-K and other filingsDirector or officer change
9 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Feb 2025Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 622K)
26 Dec 20248-K and other filingsCompleted an acquisition or asset sale
9 Sep 20248-K and other filingsDirector or officer change
9 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 May 20248-K and other filingsDirector or officer change
17 May 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Apr 20248-K and other filingsMaterial cybersecurity incident
2 Jan 2024Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.6M (2023-12-15); 2.0x the same period a year earlier
12 Dec 2023Sharp changeShort interest spike: short interest spike, 3.1M vs usual 1.6M (2023-11-30); 2.1x the same period a year earlier
5 Dec 20238-K and other filingsChanged its auditor
28 Nov 2023Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.6M (2023-11-15); 1.9x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 2.9M vs usual 1.6M (2023-10-31); 1.5x the same period a year earlier
20 Jul 20238-K and other filingsDirector or officer change
16 May 2023Sharp changeQuarterly revenue change: quarterly revenue change, 155.0M vs usual 65.6M (2023-03-31); 2.3x the same period a year earlier
16 May 20238-K and other filingsDirector or officer change
9 May 2023Sharp changeFederal obligations jump: federal obligations jump, 30.9M vs usual 20K in the same month of earlier years (2023-04-01..2023-04-30); 268556.6x the same month a year earlier
16 Mar 20238-K and other filingsDirector or officer change
16 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Mar 2023Sharp changeQuarterly revenue change: quarterly revenue change, 123.1M vs usual 63.2M (2022-12-31); 1.9x the same period a year earlier
10 Jan 2023Sharp changeFederal obligations jump: federal obligations jump, 10.5M vs usual 16K in the same month of earlier years (2022-12-01..2022-12-31); 4.4x the same month a year earlier
15 Nov 2022Sharp changeQuarterly revenue change: quarterly revenue change, 116.5M vs usual 60.7M (2022-09-30); 2.2x the same period a year earlier
14 Nov 20228-K and other filingsDirector or officer change
14 Nov 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Oct 2022Lobbying filinglobbying engagement terminated (CROSSROADS STRATEGIES, LLC)
11 Oct 2022Sharp changeFederal obligations jump: federal obligations jump, 8.6M vs usual 2,705 in the same month of earlier years (2022-09-01..2022-09-30); 0.0x the same month a year earlier
30 Aug 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 264K)
12 Aug 20228-K and other filingsDirector or officer change
9 Jun 20228-K and other filingsDirector or officer change
26 May 20228-K and other filingsDirector or officer change
18 May 20228-K and other filingsDirector or officer change
23 Mar 20228-K and other filingsDirector or officer change
7 Feb 2022Lobbying filingnew lobbying registration (CROSSROADS STRATEGIES, LLC)
7 Feb 2022Sharp changeFirst lobbying registration: first lobbying registration: SENSE BIODETECTION LTD.: new lobbying registration (CROSSROADS STRATEGIES, LLC)
10 Jan 20228-K and other filingsDirector or officer change
6 Jan 20228-K and other filingsDirector or officer change
23 Dec 2021Sharp changeFirst award from a new federal agency: first award from a new federal agency (Department of Defense): ORASURE TECHNOLOGIES INC: new Department of Defense contract SPE2DS21F0125 ($56,423,400)
Insider net buying (open market)
Month from 1 Aug 2022: $264K published
Month from 1 Sep 2022: $25K published
Month from 1 Jun 2023: $493K published
Month from 1 Aug 2023: -$11K published
Month from 1 Dec 2023: -$194K published
Month from 1 Feb 2025: $622K published
Month from 1 Mar 2025: $139K published
Month from 1 Dec 2025: $5K published
Month from 1 Mar 2026: $321K published
Month from 1 May 2026: $225K published
H-1B/E-3 applications certified
Quarter from 1 Apr 2024: 1 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Oct 2024: 1 published
Quarter from 1 Jan 2026: 2 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $63.6M, +1.1% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $67.7M, +16% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $80.2M, +39% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $116.5M, +116% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $123.1M, +94% on a year earlier; public on 4 Mar 2023
Quarter ended 31 Mar 2023: $155.0M, +129% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $85.4M, +6.5% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $89.2M, -23% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $75.9M, -38% on a year earlier; public on 12 Mar 2024
Quarter ended 31 Mar 2024: $54.1M, -65% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $54.3M, -36% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $39.9M, -55% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $37.4M, -51% on a year earlier; public on 8 Mar 2025
Quarter ended 31 Mar 2025: $29.9M, -45% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $31.2M, -43% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $27.1M, -32% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $26.8M, -29% on a year earlier; public on 10 Mar 2026
Quarter ended 31 Mar 2026: $27.9M, -6.7% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $30.6M, -1.9% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $30.9M, +14% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $9.1M, -41% on a year earlier; public on 2 Mar 2022
Quarter ended 30 Jun 2022: $5.2M, -56% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $2.6M, -42% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Mar 2023: $1.2M; public on 11 May 2023
Quarter ended 30 Jun 2023: $1.7M, -67% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $1.6M, -39% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Mar 2024: $1.6M, +33% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $1.6M, -5.0% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $145K, -91% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $456K; public on 8 Mar 2025
Quarter ended 31 Mar 2025: $420K, -73% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $1.9M, +20% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $919K, +534% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $922K, +102% on a year earlier; public on 10 Mar 2026
Quarter ended 31 Mar 2026: $913K, +117% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $2.4M, +25% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $1.7M, +82% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 170; public on 14 Feb 2022
31 Mar 2022 report: 175; public on 16 May 2022
30 Jun 2022 report: 178; public on 15 Aug 2022
30 Sep 2022 report: 173; public on 14 Nov 2022
31 Dec 2022 report: 177; public on 14 Feb 2023
31 Mar 2023 report: 189; public on 15 May 2023
30 Jun 2023 report: 191; public on 14 Aug 2023
30 Sep 2023 report: 197; public on 14 Nov 2023
31 Dec 2023 report: 209; public on 14 Feb 2024
31 Mar 2024 report: 224; public on 15 May 2024
30 Jun 2024 report: 196; public on 14 Aug 2024
30 Sep 2024 report: 182; public on 14 Nov 2024
31 Dec 2024 report: 187; public on 14 Feb 2025
31 Mar 2025 report: 174; public on 15 May 2025
30 Jun 2025 report: 150; public on 14 Aug 2025
30 Sep 2025 report: 139; public on 14 Nov 2025
31 Dec 2025 report: 134; public on 17 Feb 2026
31 Mar 2026 report: 134; public on 15 May 2026
30 Jun 2026 report: 149; public on 14 Aug 2026
30 Sep 2026 report: 146; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $165.4M published
Month from 1 Jan 2022: $388.6M published
Month from 1 Feb 2022: $1.0M published
Month from 1 Mar 2022: $2.8M published
Month from 1 Apr 2022: $5.3M published
Month from 1 May 2022: $3.0M published
Month from 1 Jun 2022: $520 published
Month from 1 Jul 2022: $115 published
Month from 1 Aug 2022: $11K published
Month from 1 Sep 2022: $396K published
Month from 1 Oct 2022: $8.6M published
Month from 1 Nov 2022: $1K published
Month from 1 Dec 2022: $10.5M published
Month from 1 Jan 2023: $635 published
Month from 1 Feb 2023: $500 published
Month from 1 Mar 2023: $53.6M published
Month from 1 Apr 2023: $30.9M published
Month from 1 May 2023: $0 published
Month from 1 Jun 2023: $444 published
Month from 1 Jul 2023: -$1K published
Month from 1 Aug 2023: -$30.9M published
Month from 1 Sep 2023: $12.6M published
Month from 1 Nov 2023: $390 published
Month from 1 Dec 2023: $1K published
Month from 1 Jan 2024: $830 published
Month from 1 Feb 2024: $250 published
Month from 1 Apr 2024: -$6.5M published
Month from 1 May 2024: -$326 published
Month from 1 Jun 2024: $415 published
Month from 1 Jul 2024: -$500 published
Month from 1 Aug 2024: -$65K published
Month from 1 Sep 2024: $239K published
Month from 1 Oct 2024: -$825 published
Month from 1 Nov 2024: $0 published
Month from 1 Dec 2024: -$351 published
Month from 1 Jan 2025: $0 published
Month from 1 Feb 2025: $449 published
Month from 1 Mar 2025: $0 published
Month from 1 May 2025: $50.0 published
Month from 1 Jun 2025: $75.0 published
Month from 1 Aug 2025: $125 published
Month from 1 Sep 2025: $239K published
Month from 1 Nov 2025: -$665 published
Month from 1 Dec 2025: -$275 published
Month from 1 Feb 2026: -$2K published
Month from 1 May 2026: -$39K published
Month from 1 Jun 2026: $239K published
Month from 1 Jul 2026: -$47K published
Month from 1 Aug 2026: $143K published
Lobbying spend
Quarter from 1 Jan 2022: $10K published
Quarter from 1 Apr 2022: $50K published
Quarter from 1 Jul 2022: $50K published
Quarter from 1 Oct 2022: $10K published
Quarter from 1 Jan 2023: $10K published
Quarter from 1 Apr 2023: $10K published
Quarter from 1 Oct 2026: $10K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $225K (14 May 2026), 2.4× its normal reading; higher than 96% of its own history.
  • Insider net buying (open market): Insiders bought a net $551K in the last 12 months (the 12 months before: $761K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $30.9M in the latest quarter, +14% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 75 insider trades

No trades in the last 90 days; the latest was filed 14 May 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
14 May 2026Steven Kyle BoydDirectorBuy75,000$3.00$225KForm 4
23 Mar 2026Kenneth J McGrathChief Financial OfficerBuyplanned in advance (10b5-1)32,300$2.93$95KForm 4
23 Mar 2026Manner Carrie EglintonPresident & CEOBuyplanned in advance (10b5-1)32,300$2.93$95KForm 4
16 Mar 2026Kenneth J McGrathChief Financial OfficerBuyplanned in advance (10b5-1)22,021$3.00$66KForm 4
16 Mar 2026Manner Carrie EglintonPresident & CEOBuyplanned in advance (10b5-1)22,022$3.00$66KForm 4
2 Dec 2025Nancy J GaglianoDirectorBuy2,100$2.37$5KForm 4
3 Mar 2025Manner Carrie EglintonPresident & CEOBuy28,670$3.49$100KForm 4
3 Mar 2025Nancy J GaglianoDirectorBuy12,750$3.08$39KForm 4

146 institutions reported shares at the end of Q3 2026, 82% of the shares outstanding; 17 opened a position, 19 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.6.1M8.80%$23.8M-183K-2.9%
Neuberger Berman Group LLC4.1M5.92%$16.0M-596K-13%
Yorkville Advisors Global, LP3.9M5.69%$15.4MNew+3.9M
Altai Capital Management, L.P.3.6M5.23%No change
Private Management Group Inc3.2M4.61%$12.5M-618K-16%
Systematic Financial Management LP3.1M4.56%$12.3M+290K+10%
Vanguard Capital Management LLC2.9M4.20%$11.4M-119K-3.9%
Dimensional Fund Advisors LP2.3M3.27%$8.8M-85K-3.6%
Acadian Asset Management LLC2.0M2.93%No change
Renaissance Technologies LLC2.0M2.83%$7.7M-61K-3.0%

Federal contracts

All 14 federal contracts

No new award in 12 months; the latest was signed 20 Sep 2023. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
20 Sep 2023Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$5.7MOVER THE COUNTER (OTC) COVID-19 TESTSUSAspending
22 Dec 2022Department of DefenseDefense Logistics Agency$53.6M8509606733!INTELISWAB COVID-19 RAPID TEUSAspending
12 Dec 2022Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$10.5MTHE PURPOSE OF THIS CONTRACT IS TO PROCURE OVER THE COUNTER (OTC) COVID-19 TESTS.USAspending
27 Sep 2022Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response$8.6MTHE OBJECTIVE OF THIS CONTRACT IS TO DEVELOP A SECOND-GENERATION ASSAY FOR THE ORAQUICK EBOLA RAPID ANTIGEN TEST AS A SUSTAINABLE, ENHANCED TEST INCLUDING ALTERNATIVE REAGENTS (ANTIBODY AND ANTIGEN) WITH CONTINUED AVAILABILITY, EXTENDED SHELF-LIFE, AUSAspending
30 Jan 2022Department of DefenseDefense Logistics Agency$3.0M8508838464!TEST KIT,CORONAVIRUUSAspending
16 Jan 2022Department of DefenseDefense Logistics Agency$3.0M8508810560!TEST KIT,CORONAVIRUUSAspending
12 Jan 2022Department of DefenseDefense Logistics Agency$2.4M8508799069!TEST KIT,CORONAVIRUUSAspending
15 Dec 2021Department of DefenseDefense Logistics Agency$1.5M8508750733!TEST KIT,CORONAVIRUUSAspending

Company events

All 64 company events

In 12 months: 3 director or officer changes, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
3 Jun 2026Director or officer changeSame filing: changed its bylaws or fiscal year, shareholder vote results8-K
17 Apr 2026Director or officer change; Signed a major agreement8-K
5 Mar 2026Director or officer change8-K
28 Oct 2025Director or officer change8-K
14 May 2025Director or officer changeSame filing: shareholder vote results8-K
9 May 2025Director or officer change8-K
26 Dec 2024Signed a major agreement; Completed an acquisition or asset sale8-K
9 Sep 2024Director or officer change8-K

Reported lobbying spend: $10K in Q3 2026, $10K in Q1 2023. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jul 2022EndedCrossroads Strategies, LLCfor Sense Biodetection Ltd.Not statedFiling
10 Jan 2022NewCrossroads Strategies, LLCfor Sense Biodetection Ltd.FDA Emergency Use Authorization of molecular test to detect COVID-19.MEDFiling
31 Dec 2008EndedOrasure Technologies, Incfor Orasure Technologies IncContinued awareness of Oral Fluid Rapid HIV TestingHealth issuesFiling
13 Aug 2007NewOrasure Technologies, Incfor Orasure Technologies IncALC, Health issues, Medicare/Medicaid, FOO, MEDFiling
11 Jul 2006NewHealth And Medicine Counselfor Orasure Technologies IncHealth issues, BudgetFiling
31 Dec 2002EndedVan Scoyoc Associatesfor Orasure TechnologiesNot statedFiling
15 Nov 2000NewVan Scoyoc Associatesfor Orasure TechnologiesBudget, MEDFiling

The 5 newest of 61 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

16 May 2023confirmed

Confirmed across sources Government contracts and Filings + Financials

OraSure Technologies (OSUR): booked $30.9M in federal contract and grant obligations in April 2023, 268,557× the same month last year, while it reported revenue of $155.0M for the quarter ended 31 Mar 2023, 2.3× the same quarter last year. Two unrelated kinds of activity within 7 days.

  • Government contracts: Federal obligations jump, became public on 4 May 2023
  • Financials: Quarterly revenue change, became public on 16 May 2023
2018-04-01: $67K2019-04-01: $20K2020-04-01: $710K2021-04-01: $6152022-04-01: $1152023-04-01: $30.9M
April 2023 against the 5 months before it. this monthearliernormal: $20K
See the evidence (2 changes)

Government contracts: Federal obligations jump became public on 4 May 2023

OraSure Technologies booked $30.9M in federal contract and grant obligations in April 2023, 268,557× the same month last year.

This period
$30.9M (April 2023)
Normal month (median of 5 earlier)
$20K
Typical spread (median absolute deviation)
$20K
How far from its usual level
+30.9
Same month last year
$115
History used
5,689 days
2018-04-01: $67K2019-04-01: $20K2020-04-01: $710K2021-04-01: $6152022-04-01: $1152023-04-01: $30.9M
April 20235 earlier monthsnormal: $20K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

Check it at the source: USAspending.gov award search.

Financials: Quarterly revenue change became public on 16 May 2023

OraSure Technologies reported revenue of $155.0M for the quarter ended 31 Mar 2023, 2.3× the same quarter last year.

This period
$155.0M (the quarter ended 31 Mar 2023)
Normal quarter (median of 8 earlier)
$65.6M
Typical spread (median absolute deviation)
$9.9M
How far from its usual level
+6.1
Same quarter last year
$67.7M
History used
4,657 days
2021-03-31: $58.6M2021-06-30: $57.6M2021-09-30: $53.9M2021-12-31: $63.6M2022-03-31: $67.7M2022-06-30: $80.2M2022-09-30: $116.5M2022-12-31: $123.1M2023-03-31: $155.0M
the quarter ended 31 Mar 20238 earlier quartersnormal: $65.6M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 3 Jun 2026Filings record

    Director or officer change

  2. 15 May 2026Insiders record

    Boyd Steven Kyle (director) bought 75,000 shares of OSUR ($224,750) (dated 14 May 2026)

  3. 17 Apr 2026Filings record

    Director or officer change

  4. 24 Mar 2026Insiders record

    McGrath Kenneth J (Chief Financial Officer) bought 32,300 shares of OSUR ($94,639) (dated 23 Mar 2026)

  5. 24 Mar 2026Insiders record

    EGLINTON MANNER CARRIE (President & CEO) bought 32,300 shares of OSUR ($94,639) (dated 23 Mar 2026)

  6. 17 Mar 2026Insiders record

    McGrath Kenneth J (Chief Financial Officer) bought 22,021 shares of OSUR ($66,063) (dated 16 Mar 2026)

  7. 17 Mar 2026Insiders record

    EGLINTON MANNER CARRIE (President & CEO) bought 22,022 shares of OSUR ($66,066) (dated 16 Mar 2026)

  8. 5 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 5 Mar 2026Filings record

    Director or officer change

  10. 3 Dec 2025Insiders record

    Gagliano Nancy J (director) bought 2,100 shares of OSUR ($4,977) (dated 2 Dec 2025)

  11. 28 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 28 Oct 2025Filings record

    Director or officer change

  13. 14 May 2025Filings record

    Director or officer change

  14. 9 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 9 May 2025Filings record

    Director or officer change

  16. 4 Mar 2025Insiders record

    EGLINTON MANNER CARRIE (President & CEO) bought 28,670 shares of OSUR ($100,058) (dated 3 Mar 2025)

  17. 4 Mar 2025Insiders record

    Gagliano Nancy J (director) bought 12,750 shares of OSUR ($39,270) (dated 3 Mar 2025)

  18. 28 Feb 2025Insiders change

    had 4 insiders buy $622K of its shares on the open market within 30 days (4 filings).

    Who bought: Eglinton Manner Carrie, Marmora Lelio, Kenny John P., McGrath Kenneth J.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $622K
    Window
    29 Jan 2025 to 28 Feb 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  19. 28 Feb 2025Insiders record

    McGrath Kenneth J (Chief Financial Officer) bought 64,000 shares of OSUR ($201,600) (dated 27 Feb 2025)

  20. 28 Feb 2025Insiders record

    Kenny John P. (director) bought 47,659 shares of OSUR ($151,079) (dated 27 Feb 2025)

  21. 28 Feb 2025Insiders record

    Marmora Lelio (director) bought 7,000 shares of OSUR ($21,420) (dated 27 Feb 2025)

  22. 28 Feb 2025Insiders record

    EGLINTON MANNER CARRIE (President & CEO) bought 78,625 shares of OSUR ($247,669) (dated 27 Feb 2025)

  23. 26 Dec 2024Filings record

    Completed an acquisition or asset sale

  24. 9 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 9 Sep 2024Filings record

    Director or officer change

  26. 17 May 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 17 May 2024Filings record

    Director or officer change

  28. 12 Apr 2024Filings record

    Material cybersecurity incident

  29. 28 Dec 2023Short interest and volume change

    had 3.3M shares sold short in the 15 Dec 2023 report, 2.0× the same report last year.

    Same report last year: 1.6M; its normal report is 1.6M.

    See the evidence
    This period
    3.3M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    306K
    How far from its usual level
    +3.7
    Same report last year
    1.6M
    History used
    2,177 days
    2022-12-15: 1.6M2022-12-30: 1.6M2023-01-13: 1.4M2023-01-31: 1.4M2023-02-15: 1.2M2023-02-28: 1.3M2023-03-15: 1.6M2023-03-31: 1.4M2023-04-14: 1.3M2023-04-28: 1.3M2023-05-15: 1.5M2023-05-31: 1.4M2023-06-15: 1.6M2023-06-30: 1.7M2023-07-14: 1.9M2023-07-31: 2.5M2023-08-15: 2.5M2023-08-31: 2.5M2023-09-15: 2.3M2023-09-29: 2.7M2023-10-13: 2.7M2023-10-31: 2.9M2023-11-15: 3.3M2023-11-30: 3.1M2023-12-15: 3.3M
    the 15 Dec 2023 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 12 Dec 2023Short interest and volume change

    had 3.1M shares sold short in the 30 Nov 2023 report, 2.1× the same report last year.

    Same report last year: 1.5M; its normal report is 1.6M.

    See the evidence
    This period
    3.1M (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    268K
    How far from its usual level
    +3.9
    Same report last year
    1.5M
    History used
    2,162 days
    2022-11-30: 1.5M2022-12-15: 1.6M2022-12-30: 1.6M2023-01-13: 1.4M2023-01-31: 1.4M2023-02-15: 1.2M2023-02-28: 1.3M2023-03-15: 1.6M2023-03-31: 1.4M2023-04-14: 1.3M2023-04-28: 1.3M2023-05-15: 1.5M2023-05-31: 1.4M2023-06-15: 1.6M2023-06-30: 1.7M2023-07-14: 1.9M2023-07-31: 2.5M2023-08-15: 2.5M2023-08-31: 2.5M2023-09-15: 2.3M2023-09-29: 2.7M2023-10-13: 2.7M2023-10-31: 2.9M2023-11-15: 3.3M2023-11-30: 3.1M
    the 30 Nov 2023 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 5 Dec 2023Filings record

    Changed its auditor

  32. 28 Nov 2023Short interest and volume change

    had 3.3M shares sold short in the 15 Nov 2023 report, 1.9× the same report last year.

    Same report last year: 1.7M; its normal report is 1.6M.

    See the evidence
    This period
    3.3M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    234K
    How far from its usual level
    +4.9
    Same report last year
    1.7M
    History used
    2,147 days
    2022-11-15: 1.7M2022-11-30: 1.5M2022-12-15: 1.6M2022-12-30: 1.6M2023-01-13: 1.4M2023-01-31: 1.4M2023-02-15: 1.2M2023-02-28: 1.3M2023-03-15: 1.6M2023-03-31: 1.4M2023-04-14: 1.3M2023-04-28: 1.3M2023-05-15: 1.5M2023-05-31: 1.4M2023-06-15: 1.6M2023-06-30: 1.7M2023-07-14: 1.9M2023-07-31: 2.5M2023-08-15: 2.5M2023-08-31: 2.5M2023-09-15: 2.3M2023-09-29: 2.7M2023-10-13: 2.7M2023-10-31: 2.9M2023-11-15: 3.3M
    the 15 Nov 2023 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 10 Nov 2023Short interest and volume change

    had 2.9M shares sold short in the 31 Oct 2023 report, 1.5× the same report last year.

    Same report last year: 2.0M; its normal report is 1.6M.

    See the evidence
    This period
    2.9M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    234K
    How far from its usual level
    +3.8
    Same report last year
    2.0M
    History used
    2,132 days
    2022-10-31: 2.0M2022-11-15: 1.7M2022-11-30: 1.5M2022-12-15: 1.6M2022-12-30: 1.6M2023-01-13: 1.4M2023-01-31: 1.4M2023-02-15: 1.2M2023-02-28: 1.3M2023-03-15: 1.6M2023-03-31: 1.4M2023-04-14: 1.3M2023-04-28: 1.3M2023-05-15: 1.5M2023-05-31: 1.4M2023-06-15: 1.6M2023-06-30: 1.7M2023-07-14: 1.9M2023-07-31: 2.5M2023-08-15: 2.5M2023-08-31: 2.5M2023-09-15: 2.3M2023-09-29: 2.7M2023-10-13: 2.7M2023-10-31: 2.9M
    the 31 Oct 2023 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 26 Sep 2023Government contracts record

    ORASURE TECHNOLOGIES INC: new Department of Health and Human Services contract 75A50223C00044 ($5.7M) (dated 20 Sep 2023)

  35. 20 Jul 2023Filings record

    Director or officer change

  36. 1 Jun 2023Insiders record

    McGrath Kenneth J (Chief Financial Officer) bought 100,000 shares of OSUR ($493,000) (dated 31 May 2023)

  37. 16 May 2023several at once

    booked $30.9M in federal contract and grant obligations in April 2023, 268,557× the same month last year, while it reported revenue of $155.0M for the quarter ended 31 Mar 2023, 2.3× the same quarter last year. Two unrelated kinds of activity within 7 days.

    See the evidence (2 changes)

    Government contracts: Federal obligations jump became public on 4 May 2023

    OraSure Technologies booked $30.9M in federal contract and grant obligations in April 2023, 268,557× the same month last year.

    This period
    $30.9M (April 2023)
    Normal month (median of 5 earlier)
    $20K
    Typical spread (median absolute deviation)
    $20K
    How far from its usual level
    +30.9
    Same month last year
    $115
    History used
    5,689 days
    2018-04-01: $67K2019-04-01: $20K2020-04-01: $710K2021-04-01: $6152022-04-01: $1152023-04-01: $30.9M
    April 20235 earlier monthsnormal: $20K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

    Financials: Quarterly revenue change became public on 16 May 2023

    OraSure Technologies reported revenue of $155.0M for the quarter ended 31 Mar 2023, 2.3× the same quarter last year.

    This period
    $155.0M (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    $65.6M
    Typical spread (median absolute deviation)
    $9.9M
    How far from its usual level
    +6.1
    Same quarter last year
    $67.7M
    History used
    4,657 days
    2021-03-31: $58.6M2021-06-30: $57.6M2021-09-30: $53.9M2021-12-31: $63.6M2022-03-31: $67.7M2022-06-30: $80.2M2022-09-30: $116.5M2022-12-31: $123.1M2023-03-31: $155.0M
    the quarter ended 31 Mar 20238 earlier quartersnormal: $65.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  38. 16 May 2023Financials change

    reported revenue of $155.0M for the quarter ended 31 Mar 2023, 2.3× the same quarter last year.

    Same quarter last year: $67.7M; its normal quarter is $65.6M.

    See the evidence
    This period
    $155.0M (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    $65.6M
    Typical spread (median absolute deviation)
    $9.9M
    How far from its usual level
    +6.1
    Same quarter last year
    $67.7M
    History used
    4,657 days
    2021-03-31: $58.6M2021-06-30: $57.6M2021-09-30: $53.9M2021-12-31: $63.6M2022-03-31: $67.7M2022-06-30: $80.2M2022-09-30: $116.5M2022-12-31: $123.1M2023-03-31: $155.0M
    the quarter ended 31 Mar 20238 earlier quartersnormal: $65.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  39. 16 May 2023Filings record

    Director or officer change

  40. 4 May 2023Government contracts change

    booked $30.9M in federal contract and grant obligations in April 2023, 268,557× the same month last year.

    Same month last year: $115; its normal month is $20K.

    See the evidence
    This period
    $30.9M (April 2023)
    Normal month (median of 5 earlier)
    $20K
    Typical spread (median absolute deviation)
    $20K
    How far from its usual level
    +30.9
    Same month last year
    $115
    History used
    5,689 days
    2018-04-01: $67K2019-04-01: $20K2020-04-01: $710K2021-04-01: $6152022-04-01: $1152023-04-01: $30.9M
    April 20235 earlier monthsnormal: $20K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

Showing the newest 40 of 134 entries; narrow the window or the kind of data to see older ones.

Not listed: 167 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001116463
Ticker
OSUR
Domain
orasure.com
Employer name
ORASURE TECHNOLOGIES, INC. (1 unverified)
Hq location
PA|BETHLEHEM|18015 (1 unverified)
Lobbying client
orasure technologies, sense biodetection
Name
BioMedomics, Inc, DNA Genotek Inc, OraSure Technologies Inc, Sense Biodetection Limited and 1 more
Uei
HGF7SBHLMRD9, Y79RWFLHWDM6
Wikipedia
OraSure Technologies
  • DOL H-1B labor condition applications and PERM certifications40 data points12 Oct 2020 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)7 records, 231 data points15 Nov 2000 to 30 Sep 2026
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)166 records3 Feb 2016 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1194 data points31 Dec 2008 to 2 Nov 2026
  • SEC Form 4 insider transactions75 records, 188 data points31 Aug 2016 to 14 May 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards14 records, 1839 data points2 Oct 2007 to 17 Aug 2026
  • Wikipedia pageviews11 data points11 Nov 2026 to 21 Nov 2026